152 related articles for article (PubMed ID: 2941187)
21. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
Lisse K; Schürenkämper P; Friedrich W; Rutkowsky J
Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
[TBL] [Abstract][Full Text] [Related]
22. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
Azziz R; Rafi A; Smith BR; Bradley EL; Zacur HA
J Clin Endocrinol Metab; 1990 Feb; 70(2):431-6. PubMed ID: 2137133
[TBL] [Abstract][Full Text] [Related]
23. Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection.
Wu XK; Zhou SY; Sallinen K; Pöllänen P; Erkkola R
Eur J Endocrinol; 2000 Sep; 143(3):383-8. PubMed ID: 11022181
[TBL] [Abstract][Full Text] [Related]
24. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.
Lobo RA
Clin Obstet Gynaecol; 1985 Sep; 12(3):633-47. PubMed ID: 2933204
[TBL] [Abstract][Full Text] [Related]
25. The production, origin and role of dehydroepiandrosterone and delta 5-androstenediol as androgen prehormones in hirsute women.
Kirschner MA; Sinhamahapatra S; Zucker IR; Loriaux L; Nieschiag E
J Clin Endocrinol Metab; 1973 Aug; 37(2):183-9. PubMed ID: 4268999
[No Abstract] [Full Text] [Related]
26. Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.
Glintborg D; Altinok ML; Petersen KR; Ravn P
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25616651
[TBL] [Abstract][Full Text] [Related]
27. Steroid secretory characteristics of a virilizing adrenal adenoma in a woman.
Bradshaw KD; Milewich L; Mason JI; Parker CR; MacDonald PC; Carr BR
J Endocrinol; 1994 Feb; 140(2):297-307. PubMed ID: 8169562
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of hirsutism and hyperandrogenemia.
Maroulis GB
Fertil Steril; 1981 Sep; 36(3):273-305. PubMed ID: 6456938
[No Abstract] [Full Text] [Related]
29. Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
Klein H; Bressel M; Kastendieck H; Voigt KD
Am J Clin Oncol; 1988; 11 Suppl 2():S30-6. PubMed ID: 2853935
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
[TBL] [Abstract][Full Text] [Related]
31. Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome.
Puzigaća Z; Prelević GM; Stretenović Z; Balint-Perić L
Gynecol Endocrinol; 1991 Sep; 5(3):167-74. PubMed ID: 1837973
[TBL] [Abstract][Full Text] [Related]
32. Strategic approach of hyperandrogenism in women.
Tourniaire J; Pugeat M
Horm Res; 1983; 18(1-3):125-34. PubMed ID: 6309640
[TBL] [Abstract][Full Text] [Related]
33. The investigation and management of hirsutism.
Franks S
J Fam Plann Reprod Health Care; 2012 Jul; 38(3):182-6. PubMed ID: 22787248
[TBL] [Abstract][Full Text] [Related]
34. Estrogen replacement therapy: effects on the endogenous androgen milieu.
Simon JA
Fertil Steril; 2002 Apr; 77 Suppl 4():S77-82. PubMed ID: 12007908
[TBL] [Abstract][Full Text] [Related]
35. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic hirsutism--an ovarian abnormality.
Kirschner MA; Zucker IR; Jespersen D
N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
[TBL] [Abstract][Full Text] [Related]
37. Relationship of androgens to female hirsutism and infertility.
Rosenfield RL
J Reprod Med; 1973 Sep; 11(3):87-95. PubMed ID: 4273087
[No Abstract] [Full Text] [Related]
38. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
39. Female hirsutism: pathophysiological considerations and therapeutic implications.
Biffignandi P; Massucchetti C; Molinatti GM
Endocr Rev; 1984; 5(4):498-513. PubMed ID: 6094172
[No Abstract] [Full Text] [Related]
40. Editorial: Endocrine function in hirsute women.
Forbes AP
N Engl J Med; 1976 Mar; 294(12):665-7. PubMed ID: 128695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
